Answers are grounded in this paper and cite their sources.
Analysis explores precision medicine strategies and their impact on healthcare outcomes, suggesting limitations.
By targeting treatment according to molecular biomarkers, precision medicine promises a revolution in healthcare. We examine this promise by distinguishing three precision medicine strategies: biomarker-stratified-high-risk-targeting, biomarker-based-individual-targeting, and biomarker-based-disease-targeting. Each strategy seeks to boost one of the determinants of the population impact of a medical intervention. We conclude that these strategies give a molecular coating to decades-old tactics. There is no compelling reason to believe that precision medicine strategies are uniquely effective for sick individuals or sick populations.
No takes yet. Share an insight, caveat, or question.
Chin‐Yee et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: